I-191 is a potent, selective protease-activated receptor 2 (PAR2) antagonist
In Vitro
I-191 inhibits cytokine production as well as cytokine-related caspase cleavages via ERK1/2 signaling in HT29 colon cancer cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only.